Nanoform Finland (OSTO:NANOFS) 3-Year Revenue Growth Rate : 40.10% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Nanoform Finland 3-Year Revenue Growth Rate?

Nanoform Finland's Revenue per Share for the three months ended in Dec. 2023 was kr0.05.

During the past 12 months, Nanoform Finland's average Revenue per Share Growth Rate was -26.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 40.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 81.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of Nanoform Finland was 255.70% per year. The lowest was 40.10% per year. And the median was 75.40% per year.

Competitive Comparison of Nanoform Finland's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Nanoform Finland's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanoform Finland's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanoform Finland's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Nanoform Finland's 3-Year Revenue Growth Rate falls into.

Nanoform Finland 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Nanoform Finland (OSTO:NANOFS) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Nanoform Finland 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Nanoform Finland's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanoform Finland (OSTO:NANOFS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoform Finland PLC (OSTO:NANOFS) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

NANOFH:Finland 4YL:Germany

Address

Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790

Website

https://www.nanoform.com

Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications.

Nanoform Finland (OSTO:NANOFS) Headlines

No Headlines